BC
BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL)
NASDAQ·Technology·General
$0.70
+0.00%
Mkt Cap —
No analyst coverage available
We don't have analyst ratings or price target data for BriaCell Therapeutics Corp. Warrant expiring 2031 yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.